Literature DB >> 6832245

Cytosine arabinoside as a suicide agent for human colony forming cells.

C Dresch, N El Kebir, J Metral, A Karsdorf.   

Abstract

The fractional reduction of cloning efficiency, otherwise known as in vitro suicide, produced by HU or 3H-TdR, is considered equivalent to the fraction of colony forming cells (CFC) in S phase and is used for the evaluation of proliferation in this population. The accuracy of both agents has been discussed. We tested cytosine arabinoside (Ara-C) on normal and pathological human bone marrow GM-CFC on different parameters. A plateau of concentrations between 1 and 5 X 10(-6) M was found to be as effective as 3H-TdR in diminishing 7 to 9 day colonies. Ara-C solutions were equally effective up to 18 weeks of storage at 4 degrees C; suicide levels were unchanged between 2 X 10(5) and 5 X 10(6) cells/ml; incubation with Ara-C was not critical between 1 and 2 h. Unlike HU, Ara-C does not require strict conditions of cell concentration, incubation time or extemporaneous preparation. Compared with 3H-TdR, Ara-C is easy to handle and does not show a decrease in cell cloning with the duration of the culture suggesting a prolonged action of the drug. Results on cell killing are comparable with the three drugs on day 7 to 9 colonies and we conclude that Ara-C is a reliable agent for suicide studies on human bone marrow GM-CFC.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832245

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  2 in total

1.  Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type.

Authors:  G C Bagby; C A Dinarello; R C Neerhout; D Ridgway; E McCall
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

2.  Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction.

Authors:  Francesca Romana Santoni de Sio; Paolo Cascio; Anna Zingale; Mauro Gasparini; Luigi Naldini
Journal:  Blood       Date:  2006-02-09       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.